Australia markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
116.30-2.57 (-2.16%)
At close: 4:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
50,195,000
45,804,000
33,266,000
32,753,000
28,216,000
Cost of revenue
17,658,000
15,387,000
7,439,000
7,718,000
7,040,000
Gross profit
32,537,000
30,417,000
25,827,000
25,035,000
21,176,000
Operating expenses
Research development
6,960,000
6,557,000
6,407,000
10,329,000
4,982,000
Selling general and administrative
12,446,000
11,299,000
6,942,000
7,399,000
6,275,000
Total operating expenses
19,406,000
17,856,000
12,459,000
18,228,000
11,257,000
Operating income or loss
13,131,000
12,561,000
13,368,000
6,807,000
9,919,000
Interest expense
2,523,000
2,454,000
1,784,000
1,348,000
1,150,000
Total other income/expenses net
-6,490,000
-6,883,000
-3,433,000
-466,000
-1,188,000
Income before tax
4,167,000
3,398,000
8,426,000
5,197,000
7,727,000
Income tax expense
-1,000,000
-1,224,000
544,000
-490,000
2,418,000
Income from continuing operations
5,167,000
4,622,000
7,882,000
5,687,000
5,309,000
Net income
5,159,000
4,616,000
7,882,000
5,687,000
5,309,000
Net income available to common shareholders
5,099,000
4,556,000
7,842,000
5,657,000
5,283,000
Basic EPS
-
2.62
5.33
3.85
3.33
Diluted EPS
-
2.62
5.28
3.66
3.30
Basic average shares
-
1,765,133
1,478,911
1,478,824
1,592,131
Diluted average shares
-
1,765,133
1,484,000
1,546,000
1,603,000
EBITDA
-
12,323,000
12,227,000
8,310,000
10,378,000